Compare iShares 10 20 Year Treasury Bond ETF (TLH) vs 10X Genomics Inc (TXG) Price & Performance

TLH, an iShares 10-20 Year Treasury Bond ETF, trades at $92.19, up 0.81% on the day. The technical outlook is bearish based on moving averages, with neutral oscillators. Recent news highlights a challenging bond market environment, with Treasury yields reaching multi-decade highs, driving increased trading volume in the ETF. The fund continues its dividend distributions, with recent payments around $0.36-$0.38 per share.

The outlook for TLH is heavily influenced by the trajectory of long-term interest rates. Rising yields pressure bond prices, presenting headwinds, though the ETF offers income via dividends. Key risks include further Fed tightening and persistent inflation. Investors should weigh the income stability against potential capital depreciation in a rising rate environment.

10x Genomics (TXG) trades at $77.28, up 1.55% on the day, with a bearish technical signal from moving averages. The company shows improving fundamentals with revenue of $642.82M in 2025 and a reduced net loss of -$43.54M, while recent news highlights strong demand for its Atera spatial biology platform and a patent victory. Positive earnings beats in recent quarters contrast with a high EV/EBITDA of 249.22, indicating significant growth expectations are priced in.

The outlook is mixed; analyst consensus is neutral with a $74.30 price target slightly below the current price, yet operational cash flow turned strongly positive in 2025. Key risks include persistent net losses, high valuation multiples, and execution on new product launches. The stock's near-term direction hinges on Atera's commercial success and achieving profitability.